The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French pharmaceutical and healthcare company, represents an essential step toward strengthening Iraq’s pharmaceutical industry.

During his participation in a scientific workshop on biosimilar medicines and intellectual property, Deputy Health Minister Hani al-Oqabi explained that the agreement reached with Sanofi is not limited to the pharmaceutical industry but includes other important areas, according to the state-run news agency (INA).

Iraqi Prime Minister Mohammed Shia al-Sudani has lately been focusing on developing collaboration with international enterprises and seeking investments to build industries in Iraq, according to al-Oqabi.